Source: Orthopedics This Week Inc
The board of directors of the American Academy of Orthopaedic Surgeons (AAOS) has approved a new position statement that urges orthopedic surgeons and patients to be fully aware of the risks and benefits of stem cell and other biologic treatments for musculoskeletal joint conditions.
Sanford started the two U.S. Food and Drug Administration-approved clinical trials — one a month ago and the other earlier this year — using abdominal fat stem cells to heal small and partial thickness tears in the rotator cuff and ulcers, said Dr. David Pearce, president of Sanford Research in Sioux Falls, S.D.
How do stem cells work? We know some things. For example, stem cells can both differentiate (turn into) another cell and excrete chemicals to coordinate a repair response. They can transfer good mitochondrial batteries to a dying cell with bad batteries. They can also transfer some of their RNA into another cell and make it produce proteins. Now a new study also suggests that stem cells injected into a joint may be able to wake up local cartilage repair cells.
Source: Medical Xpress
The truth came crashing home last year—a perfect storm of faulty genetics, the unrelenting march of age, and every athletic mishap I've ever stumbled through.
Source: The San Diego Union-Tribune
Those looking for legitimate stem cell treatments face bewildering choices about where to go and which of the many kinds of stem cells are best for their condition.
Dennis Matko was headed for a knee replacement when he discovered a new therapy that would instead inject his own stem cells and plasma into the joint to help prevent degradation. The 69-year-old Clintonville resident said he had been pretty active in his 50s, leading to problems with the right knee. He eventually had his meniscus removed. He had been through physical therapy, cortisone shots and gel injections, but the pain persisted.
Source: Science Daily
Whether using embryonic or adult stem cells, coercing these master cells to convert to the desired target cell and reproduce flawlessly is difficult. Now an international team of researchers has a two-part system that can convert the cells to the targets and then remove the remnants of that conversion, leaving only the desired DNA behind to duplicate.